Nova Leap Health Corp.
NVLPF
$0.2382
$0.01868.47%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.08% | 7.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.08% | 7.71% | |||
| Cost of Revenue | 10.87% | 7.86% | |||
| Gross Profit | 16.53% | 7.47% | |||
| SG&A Expenses | 6.80% | 13.15% | |||
| Depreciation & Amortization | 6.15% | 32.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.29% | 10.27% | |||
| Operating Income | 365.96% | -66.00% | |||
| Income Before Tax | -656.21% | -107.08% | |||
| Income Tax Expenses | -5,350.00% | -99.08% | |||
| Earnings from Continuing Operations | -518.14% | -108.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -518.14% | -108.83% | |||
| EBIT | 365.96% | -66.00% | |||
| EBITDA | 105.70% | -6.47% | |||
| EPS Basic | -511.11% | -108.74% | |||
| Normalized Basic EPS | -1,850.00% | -102.38% | |||
| EPS Diluted | -450.00% | -110.00% | |||
| Normalized Diluted EPS | -1,850.00% | -102.38% | |||
| Average Basic Shares Outstanding | 0.00% | 1.11% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||